Epidemiological studies indicate that most men and women will acquire a sexually
transmitted anogenital human papillomavirus (HPV) infection in their lifetimes. In addition …

Human papillomavirus (HPV) infection is commonly found in the genital tract of men and
women with or without any clinical lesion. The association of HPV DNA with several different …

Even though the incidence of anal cancer among men who have sex with men (MSM) is
higher than the incidence of cervical cancer among women, few MSM are identified as high …

This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

BACKGROUND: Two HPV vaccines prevent infection with HPV-16 and HPV-18, high-risk
(cancer-associated) HPV types which together cause approximately 70% of cervical …

Objective In the quadrivalent (types 6/11/16/18) HPV vaccine (GARDASIL®/SILGARD®)
clinical program, 73% of women aged 16-26 were naïve to all vaccine HPV types. In these …

HPV persistence is necessary for the development of anogenital cancer. Studies show that
cervical and anal HPV infections in women and in men who have sex with men are common …

Background A phase 3 trial was conducted to evaluate the efficacy of a prophylactic
quadrivalent vaccine in preventing anogenital diseases associated with human …

Abstract Background The United States (US) Food & Drug Administration (FDA) recently
approved a human papillomavirus (HPV) vaccine with the purpose of reducing the risk of …

Background Infection with human papillomavirus (HPV) and diseases caused by HPV are
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …